Company / Gross Profit
Elanco Gross Profit History
FY2023-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Gross Profit
$2.6B
FY2025
5-year range
$2.4B / $2.6B
FY2023-FY2025
Trend
+6.4%
vs FY2024
Sector context
#7 of 29
Health Care
What the data says
Elanco's gross profit of $2.6B is higher than 76% of companies in the Health Care sector (FY2025). Gross Profit remained relatively stable over the past 3 years, with values between $2.4B and $2.6B.
Based on SEC 10-K filings.
$2.6B in FY2025. Top quartile in the Health Care sector.
Improved from $2.5B to $2.6B over the past 2 years.
Health Care sector context is included.
Gross Profit over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Top 24% in Health CareTop 24% of 29This company $2.6B Sector average $3.5B
▼
-25.1% below sector average
Key checks
Key Insights
- In FY2025, gross profit increased 6.4% year-over-year.
- Ranks #7 out of 29 companies in the Health Care sector.
Company context
Key Data Points
- Altman Z-Score 0.72 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Gross ProfitValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $2.6B | +6.4% |
| FY2024 | $2.4B | -2.0% |
| FY2023 | $2.5B | - |
| FY2022 | - | - |
| FY2021 | - | - |
| FY2020 | - | - |
| FY2019 | - | - |
| FY2018 | - | - |
| FY2017 | - | - |
| FY2016 | - | - |
As of FY2025 · SEC 10-K · Updated Jul 2, 2026